Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A validation study of a retrospective venous thromboembolism risk scoring method.
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A validation study of a retrospective venous thromboembolism risk scoring method.
A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010 Feb; 251(2):344-50.
View in:
PubMed
subject areas
Adult
Aged
Humans
Middle Aged
Retrospective Studies
Risk Assessment
Venous Thromboembolism
authors with profiles
Joseph Caprini